• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ALKBH5 通过靶向 PKM2 诱导环状 RNA NRIP1 促进甲状腺癌细胞的糖酵解。

ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.

机构信息

Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.

出版信息

Cancer Sci. 2023 Jun;114(6):2318-2334. doi: 10.1111/cas.15772. Epub 2023 Mar 14.

DOI:10.1111/cas.15772
PMID:36851875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236620/
Abstract

Although circular RNAs (circRNAs) are involved in cell proliferation, differentiation, apoptosis, and invasion, the underlying regulatory mechanisms of circRNAs in thyroid cancer have not been fully elucidated. This article aimed to study the role of circRNA regulated by N6-methyladenosine modification in papillary thyroid cancer (PTC). Quantitative real-time PCR, western blotting, and immunohistochemistry were used to investigate the expressions of circRNA nuclear receptor-interacting protein 1 (circNRIP1) in PTC tissues and adjacent noncancerous thyroid tissues. In vitro and in vivo assays were carried out to assess the effects of circNRIP1 on PTC glycolysis and growth. The N6-methyladenosine mechanisms of circNRIP1 were evaluated by methylated RNA immunoprecipitation sequencing, luciferase reporter gene, and RNA stability assays. Results showed that circNRIP1 levels were significantly upregulated in PTC tissues. Furthermore, elevated circNRIP1 levels in PTC patients were correlated with high tumor lymph node metastasis stage and larger tumor sizes. Functionally, circNRIP1 significantly promoted glycolysis, PTC cell proliferation in vitro, and tumorigenesis in vivo. Mechanistically, circNRIP1 acted as a sponge for microRNA (miR)-541-5p and miR-3064-5p and jointly upregulated pyruvate kinase M2 (PKM2) expression. Knockdown of m A demethylase α-ketoglutarate-dependent dioxygenase alkB homolog 5 (ALKBH5) significantly enhanced circNRIP1 m A modification and upregulated its expression. These results show that ALKBH5 knockdown upregulates circNRIP1, thus promoting glycolysis in PTC cells. Therefore, circNRIP1 can be a prognostic biomarker and therapeutic target for PTC by acting as a sponge for oncogenic miR-541-5p and miR-3064-5p to upregulate PKM2 expression.

摘要

虽然环状 RNA(circRNA)参与细胞增殖、分化、凋亡和侵袭,但 circRNA 在甲状腺癌中的调控机制尚未完全阐明。本文旨在研究受 N6-甲基腺苷修饰调控的环状 RNA 在甲状腺乳头状癌(PTC)中的作用。采用定量实时 PCR、western blot 和免疫组织化学法检测 PTC 组织和相邻非癌性甲状腺组织中环状 RNA 核受体相互作用蛋白 1(circNRIP1)的表达。通过体外和体内实验评估 circNRIP1 对 PTC 糖酵解和生长的影响。通过甲基化 RNA 免疫沉淀测序、荧光素酶报告基因和 RNA 稳定性测定评估 circNRIP1 的 N6-甲基腺苷机制。结果表明,circNRIP1 在 PTC 组织中表达显著上调。此外,PTC 患者中 circNRIP1 水平升高与肿瘤淋巴结转移高分期和肿瘤体积增大相关。功能上,circNRIP1 显著促进了体外 PTC 细胞的糖酵解、增殖和体内肿瘤生成。机制上,circNRIP1 作为 microRNA(miR)-541-5p 和 miR-3064-5p 的海绵,共同上调丙酮酸激酶 M2(PKM2)的表达。m A 去甲基酶 α-酮戊二酸依赖性双加氧酶 alkB 同源物 5(ALKBH5)的敲低显著增强了 circNRIP1 的 m A 修饰并上调了其表达。这些结果表明,ALKBH5 的敲低上调了 circNRIP1,从而促进了 PTC 细胞的糖酵解。因此,circNRIP1 可作为 PTC 的预后生物标志物和治疗靶点,通过作为致癌 miR-541-5p 和 miR-3064-5p 的海绵,上调 PKM2 的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/bf22d168c02b/CAS-114-2318-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/8f05a2e74875/CAS-114-2318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/4439c33a7137/CAS-114-2318-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/4f13c5a4e4fb/CAS-114-2318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/7973643d2c82/CAS-114-2318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/f5c224f4d57b/CAS-114-2318-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/bf22d168c02b/CAS-114-2318-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/8f05a2e74875/CAS-114-2318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/4439c33a7137/CAS-114-2318-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/4f13c5a4e4fb/CAS-114-2318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/7973643d2c82/CAS-114-2318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/f5c224f4d57b/CAS-114-2318-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccd/10236620/bf22d168c02b/CAS-114-2318-g007.jpg

相似文献

1
ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.ALKBH5 通过靶向 PKM2 诱导环状 RNA NRIP1 促进甲状腺癌细胞的糖酵解。
Cancer Sci. 2023 Jun;114(6):2318-2334. doi: 10.1111/cas.15772. Epub 2023 Mar 14.
2
CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.环状RNA NRIP1通过吸附mir-195-5p并调节P38丝裂原活化蛋白激酶和JAK/STAT信号通路促进甲状腺乳头状癌进展。
Diagn Pathol. 2021 Oct 25;16(1):93. doi: 10.1186/s13000-021-01153-9.
3
CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.环状磷酸甘油酸脱氢酶(CircPHGDH)下调通过miR-122-5p/丙酮酸激酶M2(PKM2)轴降低甲状腺乳头状癌的进展。
BMC Cancer. 2024 Apr 23;24(1):511. doi: 10.1186/s12885-024-12199-5.
4
Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.circPUM1 通过作为 miR-21-5p 的海绵来增强 MAPK1 表达,从而抑制甲状腺乳头状癌细胞的生长、转移和糖酵解。
Genes Genomics. 2021 Feb;43(2):141-150. doi: 10.1007/s13258-020-01023-6. Epub 2021 Jan 22.
5
Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.沉默环状 RNA 蛋白激酶 C iota(circ-PRKCI)通过环状 RNA-PRKCI/miR-335/E2F3 ceRNA 轴抑制人甲状腺乳头状癌细胞的进展和糖酵解。
Endocr J. 2021 Jun 28;68(6):713-727. doi: 10.1507/endocrj.EJ20-0726. Epub 2021 Mar 13.
6
Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.环状 RNA circBACH2 通过海绵吸附 miR-139-5p 并调节 LMO4 表达在甲状腺乳头状癌中发挥作用。
Cell Death Dis. 2019 Feb 22;10(3):184. doi: 10.1038/s41419-019-1439-y.
7
Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.外泌体环状 RNA hsa_circ_007293 通过调控微小 RNA-653-5p/配对盒 6 轴促进甲状腺乳头状癌细胞的增殖、迁移、侵袭和上皮-间充质转化。
Bioengineered. 2021 Dec;12(2):10136-10149. doi: 10.1080/21655979.2021.2000745.
8
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.FTO 通过依赖于 N6-甲基腺苷的方式降低 APOE mRNA 的稳定性,从而抑制甲状腺乳头状癌细胞的糖酵解和生长。
J Exp Clin Cancer Res. 2022 Jan 28;41(1):42. doi: 10.1186/s13046-022-02254-z.
9
CircNRIP1 Exerts Oncogenic Functions in Papillary Thyroid Carcinoma by Sponging miR-653-5p and Regulating PBX3 Expression.环状核糖核酸NRIP1通过吸附微小核糖核酸-653-5p和调节PBX3表达在甲状腺乳头状癌中发挥致癌作用。
J Oncol. 2022 May 19;2022:2081501. doi: 10.1155/2022/2081501. eCollection 2022.
10
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.沉默长链非编码 RNA 烟酰胺核苷酸转氢酶反义 RNA 1 通过靶向 miR-199a-5p 抑制甲状腺乳头状癌细胞增殖、迁移和侵袭并促进细胞凋亡。
Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20.

引用本文的文献

1
Epigenetic control in thyroid cancer: mechanisms and clinical perspective.甲状腺癌中的表观遗传调控:机制与临床展望
Cell Death Discov. 2025 Aug 17;11(1):387. doi: 10.1038/s41420-025-02688-2.
2
The dual mechanism of mA demethylase ALKBH5 in regulating energy metabolism during exposure to MC-LR.甲基腺嘌呤脱甲基酶ALKBH5在暴露于微囊藻毒素-LR期间调节能量代谢的双重机制。
Cell Death Dis. 2025 Jul 3;16(1):489. doi: 10.1038/s41419-025-07791-x.
3
Prolyl 4-hydroxylase subunit alpha-2 acts as a TRIM21 ubiquitination substrate to promote papillary thyroid cancer progression via the glycolytic pathway.

本文引用的文献

1
M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.m6A 介导的 circMDK 上调促进肝癌发生,并作为肝癌的一种纳米治疗靶点。
Mol Cancer. 2022 May 6;21(1):109. doi: 10.1186/s12943-022-01575-z.
2
Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p.Hsa_circRNA_0088036 通过海绵吸附 miR-140-3p 促进膀胱癌进展。
Cell Death Dis. 2022 Apr 8;13(4):322. doi: 10.1038/s41419-022-04732-w.
3
METTL14-mediated mA modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis.
脯氨酰4-羟化酶α-2亚基作为TRIM21泛素化底物,通过糖酵解途径促进甲状腺乳头状癌进展。
Cell Death Dis. 2025 May 17;16(1):395. doi: 10.1038/s41419-025-07702-0.
4
The Role of M6A LncRNA Modification in Papillary Thyroid Cancer.m6A长链非编码RNA修饰在甲状腺乳头状癌中的作用
Int J Mol Sci. 2025 Mar 21;26(7):2833. doi: 10.3390/ijms26072833.
5
Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy.甲状腺癌代谢重编程:从机制到治疗策略
Mol Cancer. 2025 Mar 11;24(1):74. doi: 10.1186/s12943-025-02263-4.
6
The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions.N⁶-甲基腺苷(m⁶A)修饰在癌症中的作用:最新进展与未来方向
EXCLI J. 2025 Jan 15;24:113-150. doi: 10.17179/excli2024-7935. eCollection 2025.
7
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health.女性生殖中的表观遗传调控:m6A对母婴健康的影响。
Cell Death Discov. 2025 Feb 4;11(1):43. doi: 10.1038/s41420-025-02324-z.
8
The Application of microRNAs in Papillary Thyroid Cancer: A Bibliometric and Visualized Analysis.微小RNA在甲状腺乳头状癌中的应用:文献计量学与可视化分析
Int J Gen Med. 2024 Oct 15;17:4681-4699. doi: 10.2147/IJGM.S487239. eCollection 2024.
9
Non-coding RNA and drug resistance in head and neck cancer.非编码RNA与头颈癌中的耐药性
Cancer Drug Resist. 2024 Sep 20;7:34. doi: 10.20517/cdr.2024.59. eCollection 2024.
10
Role of N6-methyladenosine methylation in head and neck cancer and its regulation of innate immune pathways.N6-甲基腺苷甲基化在头颈部癌症中的作用及其对固有免疫途径的调控。
Front Immunol. 2024 Sep 30;15:1458884. doi: 10.3389/fimmu.2024.1458884. eCollection 2024.
METTL14 介导的 circORC5 的 mA 修饰通过调节 miR-30c-2-3p/AKT1S1 轴抑制胃癌进展。
Mol Cancer. 2022 Feb 14;21(1):51. doi: 10.1186/s12943-022-01521-z.
4
CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production.环状RTN4IP1通过吸附miR-541-5p诱导HIF1A产生,从而调控肝内胆管癌的恶性进展。
Pathol Res Pract. 2022 Feb;230:153732. doi: 10.1016/j.prp.2021.153732. Epub 2021 Dec 5.
5
CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.环状 RNA MTO1 通过调控 Wnt/β-catenin 信号通路和上皮间质转化抑制 miR-541-5p/ZIC1 轴抑制肝癌进展。
Cell Death Dis. 2021 Dec 20;13(1):12. doi: 10.1038/s41419-021-04464-3.
6
Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.N6-甲基腺苷修饰的 circCPSF6 通过激活 YAP1 促进肝癌恶性进展。
Cancer Res. 2022 Feb 15;82(4):599-614. doi: 10.1158/0008-5472.CAN-21-1628.
7
m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression.环状HPS5的m6A修饰与通过HMGA2表达介导的肝细胞癌进展
Mol Ther Nucleic Acids. 2021 Sep 14;26:637-648. doi: 10.1016/j.omtn.2021.09.001. eCollection 2021 Dec 3.
8
Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p.长链非编码 RNA LINC00958 通过增强含有 LEM 结构域的 1 蛋白表达促进结直肠癌进展。
Bioengineered. 2021 Dec;12(1):8100-8115. doi: 10.1080/21655979.2021.1985259.
9
LncRNA LINC00858 enhances cervical cancer cell growth through miR-3064-5p/ VMA21 axis.长链非编码 RNA LINC00858 通过 miR-3064-5p/VMA21 轴促进宫颈癌细胞生长。
Cancer Biomark. 2021;32(4):479-489. doi: 10.3233/CBM-200033.
10
circATP2B1 Promotes Aerobic Glycolysis in Gastric Cancer Cells Through Regulation of the miR-326 Gene Cluster.环状ATP2B1通过调控miR-326基因簇促进胃癌细胞的有氧糖酵解。
Front Oncol. 2021 Apr 15;11:628624. doi: 10.3389/fonc.2021.628624. eCollection 2021.